PaulRayomndKunkMD
Hematology • Charlottesville, VAAssistant Professor of Medicine, Division of Hematology Oncology, University of Virginia
Dr. Kunk is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
1240 Lee St.
Charlottesville, VA 22903Phone+1 434-924-9333Fax+1 434-244-7526- Is this information wrong?
Summary
- Dr. Paul Kunk is a hematologist in Charlottesville, VA and is affiliated with University of Virginia Medical Center. He received his medical degree from University of Tennessee Health Science Center College of Medicine and has been in practice 6 years. He is experienced in gastrointestinal cancer, esophageal cancer, gallbladder cancer, pancreatic cancer, and stomach cancer.
Education & Training
University of VirginiaCheif Fellow, Hematology-Oncology, 2014 - 2017
University of Virginia Medical CenterResidency, Internal Medicine, 2007 - 2011
University of Tennessee Health Science Center College of MedicineClass of 2011
Certifications & Licensure
FL State Medical License 2022 - 2026
DC State Medical License 2022 - 2024
NE State Medical License 2022 - 2024
VA State Medical License 2011 - 2024- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Joseph H. Farrow Research Award University of Virginia
- Excellence in Clinical Medicine Award University of Virginia
- Staff Member of the Month San Jose State University
- Join now to see all
Clinical Trials
- Futibatinib Versus Gemcitabine-Cisplatin Chemotherapy as First-Line Treatment of Patients With Advanced Cholangiocarcinoma Harboring FGFR2 Gene Rearrangements Start of enrollment: 2020 Mar 01
Roles: Contact
Publications & Presentations
PubMed
- 13 citationsARRY-382 in Combination with Pembrolizumab in Patients with Advanced Solid Tumors: Results from a Phase 1b/2 Study.Melissa Johnson, Arkadiusz Z Dudek, Ammar Sukari, Justin Call, Paul R Kunk, Karl Lewis, Justin F Gainor, John Sarantopoulos, Patrice Lee, Adele Golden, Allison Harney,...> ;Clinical Cancer Research. 2022 Jun 13
- 4 citationsMyeloid Cell Infiltration Correlates With Prognosis in Cholangiocarcinoma and Varies Based on Tumor LocationPaul R. Kunk, Sean C. Dougherty, Kevin T. Lynch, Rachel Whitehair, Max O. Meneveau, Joseph M. Obeid, Kevin Winters, Jennifer Y Ju, Edward B. Stelow, Todd W. Bauer, Cra...> ;Journal of Immunotherapy. 2021 Sep 1
- 16 citationsMismatch Repair Protein Deficiency/Microsatellite Instability Is Rare in Cholangiocarcinomas and Associated With Distinctive MorphologiesJennifer Y Ju, Megan E Dibbern, Mani S. Mahadevan, Jinbo Fan, Paul R. Kunk, Edward B. Stelow> ;American Journal of Clinical Pathology. 2020 Apr 15
- Join now to see all
Press Mentions
Your Blood Pressure & Heartburn Medicine Might Help You Survive Colon Cancer or COVIDJanuary 26th, 2022
Professional Memberships
- Member
- Member
- Member
- Phi Alpha Theta National Honors Society of HistoryMember
Hospital Affiliations
University of Virginia Medical CenterCharlottesville, Virginia
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
